Analyse
Fundierte Analysen zu Pharmamärkten, Lieferketten, Technologie und Regulierung
#US market entry ×
Analyse
1. Sept. 2026•1 Min. Lesezeit
HK Innoen's K‑Cap (Tegoprazan) Targets US Launch, Boosts Growth Prospects
Domestic drug K‑Cap (tegoprazan) is nearing US market entry, with analysts seeing royalty revenue and a shift to global growth for HK Innoen.
Analyse
30. Aug. 2026•1 Min. Lesezeit
WiseBuzz Forms US DTC Advertising Team to Support Korean Pharma Expansion
WiseBuzz announced the creation of a dedicated US Direct‑to‑Consumer advertising team to help Korean pharma and biotech firms launch DTC campaigns in the United States.